Trade JnJ ^JNJ

Numab Therapeutics and Kaken Pharmaceutical Enter Collaboration and Option Agreement for Multi-specific Antibody ND081 for Treatment of Inflammatory Bowel Disease

Johnson & Johnson (NYSE:JNJ) Stock Price Down 1.1% – Should You Sell?

Johnson & Johnson (NYSE:JNJ) Stock Price Down 1.4% - Should You Sell?

ROI Financial Advisors LLC Sells 156 Shares of Johnson & Johnson (NYSE:JNJ)

JNJ's Phase 2 Study Of Nipocalimab Shows Improvement In Disease Activity In Sjögren's Disease

Nipocalimab demonstrates significant clinical improvement in disease activity and IgG reduction in Phase 2 Sjögren’s disease study | Taiwan News | Nov. 14, 2024 23:25

Johnson & Johnson (NYSE:JNJ) Shares Sold by Ferguson Wellman Capital Management Inc.

Zions Bancorporation N.A. Acquires 19,604 Shares of Johnson & Johnson (NYSE:JNJ)

Schrum Private Wealth Management LLC Buys 3,526 Shares of Johnson & Johnson (NYSE:JNJ)

Why Is Johnson & Johnson (JNJ) Down 6.7% Since Last Earnings Report? - November 14, 2024 - Zacks.com

Johnson & Johnson (NYSE:JNJ) Shares Down 0.2% - Here's What Happened

DOJ Objects to J&J Unit Hiring Jones Day as Bankruptcy Counsel

Johnson & Johnson (NYSE:JNJ) Shares Sold by Simmons Bank

Johnson & Johnson (NYSE:JNJ) Shares Sold by Haverford Trust Co

Johnson & Johnson (NYSE:JNJ) Shares Purchased by Victory Capital Management Inc.

Aptus Capital Advisors LLC Acquires 42,059 Shares of Johnson & Johnson (NYSE:JNJ)

Cumberland Partners Ltd Boosts Stake in Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson (NYSE:JNJ) Position Increased by Savvy Advisors Inc.

Sumitomo Mitsui Trust Group Inc. Increases Stake in Johnson & Johnson (NYSE:JNJ)

WealthPLAN Partners LLC Trims Stock Holdings in Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson (NYSE:JNJ) Shares Down 1.1% - Here's Why

J&J’s Ottava robotic system approved for US pivotal trial | BioWorld

Texas Two-Step: Jones Day's Tactic to Evade Mass Tort Liability

Johnson & Johnson (NYSE:JNJ) Shares Purchased by FDx Advisors Inc.

Nations Financial Group Inc. IA ADV Boosts Stock Position in Johnson & Johnson (NYSE:JNJ)

Stand Up To Cancer partners with Johnson & Johnson to explore new treatment for AL amyloidosis

WCM Investment Management LLC Has $1.96 Million Holdings in Johnson & Johnson (NYSE:JNJ)

Nations Financial Group Inc. IA ADV Grows Stock Position in Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson (NYSE:JNJ) Stock Holdings Lifted by Chartwell Investment Partners LLC

Kennebec Savings Bank Invests $1.11 Million in Johnson & Johnson (NYSE:JNJ)

Ashton Thomas Securities LLC Buys New Holdings in Johnson & Johnson (NYSE:JNJ)

Jensen Investment Management Inc. Sells 210,244 Shares of Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson (NYSE:JNJ) Shares Sold by Arvest Investments Inc.

Johnson & Johnson (NYSE:JNJ) Stock Holdings Decreased by Los Angeles Capital Management LLC

Johnson & Johnson (NYSE:JNJ) Shares Sold by tru Independence LLC

Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial

Real-world outcomes of cataract surgeries using a new type of enhanced monofocal toric intraocular lens

Pharma and Biotech Layoffs Signal Strategic Shift Towards Efficiency Amid Industry Restructuring

Johnson & Johnson Gets Breakthrough Therapy Designation for Sjögren's Disease Treatment | Morningstar

FDA grants nipocalimab second breakthrough therapy designation By Investing.com

Nipocalimab is the first and only investigational therapy granted U.S. FDA Breakthrough Therapy Designation for the treatment of adults living with moderate-to-severe Sjögren's disease | Morningstar

Johnson & Johnson (NYSE:JNJ) Stock Price Up 0.3% - Here's What Happened

Johnson & Johnson (NYSE:JNJ) Shares Sold by Meritage Portfolio Management

Johnson & Johnson (NYSE:JNJ) Shares Sold by Crossmark Global Holdings Inc.

Tyler Stone Wealth Management Purchases 3,220 Shares of Johnson & Johnson (NYSE:JNJ)

Baker Avenue Asset Management LP Buys 4,838 Shares of Johnson & Johnson (NYSE:JNJ)

Houlihan Financial Resource Group Ltd. Buys Shares of 7,960 Johnson & Johnson (NYSE:JNJ)

Troy Asset Management Ltd Decreases Position in Johnson & Johnson (NYSE:JNJ)

Atria Investments Inc Acquires 5,426 Shares of Johnson & Johnson (NYSE:JNJ)

Nipocalimab is the First and Only Investigational Therapy Granted U.S. FDA Breakthrough Therapy Designation for the Treatment of Adults Living with Moderate-to-Severe Sjögren’s Disease - Drugs.com MedNews

Will These 5 Biotech Stocks Surpass Q3 Earnings Forecasts? - November 11, 2024 - Zacks.com

Nordwand Advisors LLC Has $123.66 Million Stock Holdings in Johnson & Johnson (NYSE:JNJ)

Verdence Capital Advisors LLC Buys 8,480 Shares of Johnson & Johnson (NYSE:JNJ)

Knowledge Nugget of the day: Patent evergreening

Johnson & Johnson (NYSE:JNJ) Shares Sold by Robert Wood Johnson Foundation

CWA Asset Management Group LLC Makes New Investment in Johnson & Johnson (NYSE:JNJ)

Equitable Trust Co. Raises Position in Johnson & Johnson (NYSE:JNJ)

AEGON ASSET MANAGEMENT UK Plc Sells 12,224 Shares of Johnson & Johnson (NYSE:JNJ)

Easterly Investment Partners LLC Boosts Stock Holdings in Johnson & Johnson (NYSE:JNJ)

Fiera Capital Corp Lowers Position in Johnson & Johnson (NYSE:JNJ)

Philip James Wealth Mangement LLC Raises Stake in Johnson & Johnson (NYSE:JNJ)

Stiles Financial Services Inc Decreases Holdings in Johnson & Johnson (NYSE:JNJ)

Robert Wood Johnson Foundation Sells 509,616 Shares of Johnson & Johnson (NYSE:JNJ)

Novel bladder cancer treatment gains MHRA approval in the UK

Uncertainty Looms Over Woody Johnson's Future as Jets Owner After Trump’s 2024 Win | NFL News - Times of India

Johnson & Johnson (NYSE:JNJ) Stock Price Down 0.1% - What's Next?

FDA Approves Johnson & Johnson’s Varipulse for Drug-Resistant Paroxysmal Atrial Fibrillation

Why Johnson & Johnson (JNJ)’s Legal Issues Could Wrap Up Quickly

Johnson & Johnson Seeks Approval Of Darzalex Faspro In US, Darzalex In EU For Myeloma Treatment

Johnson & Johnson submits applications in the U.S. and EU seeking approval of DARZALEX FASPRO®/DARZALEX® (daratumumab) as subcutaneous monotherapy for high-risk smouldering multiple myeloma | The Manila Times

Trinity Legacy Partners LLC Has $5.72 Million Position in Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson submits applications in the U.S. and EU seeking approval of DARZALEX FASPRO® / DARZALEX® as subcutaneous monotherapy for high-risk smoldering multiple myeloma By Investing.com

Castle Wealth Management LLC Sells 3,405 Shares of Johnson & Johnson (NYSE:JNJ)

Principal Financial Group Inc. Boosts Stock Holdings in Johnson & Johnson (NYSE:JNJ)

Bridgewater Advisors Inc. Has $5.01 Million Holdings in Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson (NYSE:JNJ) Shares Acquired by WoodTrust Financial Corp

Johnson & Johnson seeks FDA, EMA nod for myeloma treatment By Investing.com

Johnson & Johnson (NYSE:JNJ) Trading Down 0.6% - Time to Sell?

Johnson & Johnson advances leadership in rheumatic disease innovation with 43 abstracts at ACR 2024 | Morningstar

Johnson & Johnson MedTech Receives FDA Approval for the VARIPULSE™ Pulsed Field Ablation Platform for the Treatment of Atrial Fibrillation | Morningstar

Blake Schutter Theil Wealth Advisors LLC Takes Position in Johnson & Johnson (NYSE:JNJ)

M&G Plc Trims Stake in Johnson & Johnson (NYSE:JNJ)

Concurrent Investment Advisors LLC Increases Position in Johnson & Johnson (NYSE:JNJ)

Gordian Advisors LLC Invests $547,000 in Johnson & Johnson (NYSE:JNJ)

Radnor Capital Management LLC Takes Position in Johnson & Johnson (NYSE:JNJ)

Harvest Portfolios Group Inc. Decreases Stake in Johnson & Johnson (NYSE:JNJ)

1834 Investment Advisors Co. Sells 4,534 Shares of Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson (NYSE:JNJ) Stock Price Down 0.1% - Here's Why

7 Stagflation Stocks to Help Navigate Periods of Low Growth

Johnson & Johnson (NYSE:JNJ) Price Target Raised to $162.00

ASB Consultores LLC Has $820,000 Position in Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson (NYSE:JNJ) Shares Purchased by Avidian Wealth Enterprises LLC

Balentine LLC Buys 3,345 Shares of Johnson & Johnson (NYSE:JNJ)

Royalty Pharma Reports Third Quarter 2024 Results | Morningstar

Cornerstone Capital Inc. Has $18.71 Million Stake in Johnson & Johnson (NYSE:JNJ)

Garland Capital Management Inc. Lowers Position in Johnson & Johnson (NYSE:JNJ)

Crestwood Advisors Group LLC Boosts Stock Holdings in Johnson & Johnson (NYSE:JNJ)

Amalgamated Bank Sells 7,203 Shares of Johnson & Johnson (NYSE:JNJ)

Fed Hints at Tight Policy Amid Global Economic Uncertainty

Dogecoin surges after Elon Musk issues crypto endorsement

Week ahead: Tech rally hinges on Nvidia earnings

Stock Market Today: Indexes Drop as Fed Rate Cuts are still underway

What's Going On With Amazon Stock today? Is AMZN expected to rise?

Dogecoin surges as Trump unveils new government efficiency initiative with Musk andRamaswamy

Japanese Yen to USD: Yen drops to fresh multi-month low against USD

Asia markets today: Nikkei 225 up 0.18%, Hang Seng Index falls by 197 points